Sagredo, Onintza

Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity

Palazuelos, J., Aguado, T., Pazos, M. R., Julien, B., Carrasco, C., Resel, E., Sagredo, O., Benito, C., Romero, J., Azcoitia, I., et al. (2009) · Brain

Cannabis and Cannabinoid ResearchNeuroinflammation and Neurodegeneration Mechanisms

Cited by 382

Cannabinoid CB2receptor agonists protect the striatum against malonate toxicity: Relevance for Huntington's disease

Sagredo, O., González, S., Aroyo, I., Pazos, M. R., Benito, C., Lastres‐Becker, I., Romero, J. P., Tolón, R. M., Mechoulam, R., Brouillet, E., et al. (2009) · Glia

Cannabis and Cannabinoid ResearchNeuroinflammation and Neurodegeneration Mechanisms

Cited by 201

Cannabidiol reduced the striatal atrophy caused 3‐nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1and adenosine A2Areceptors

Sagredo, O., Ramos, J. A., Decio, A., Mechoulam, R., & Fernández‐Ruiz, J. (2007) · European Journal of Neuroscience

Cannabis and Cannabinoid ResearchParkinson's Disease Mechanisms and Treatments

Cited by 147

Neuroprotective properties of cannabigerol in Huntington's disease: studies in R6/2 mice and 3-nitropropionate-lesioned mice

Valdeolivas, S., Navarrete, C., Cantarero, I., Bellido, M. L., Muñoz, E., & Sagredo, O. (2015) · Neurotherapeutics

Cannabis and Cannabinoid ResearchGenetic Neurodegenerative Diseases

Cited by 143

Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington's disease

Sagredo, O., Pazos, M. R., Satta, V., Ramos, J. A., Pertwee, R. G., & Fernández‐Ruiz, J. (2011) · Journal of Neuroscience Research

Cannabis and Cannabinoid ResearchGenetic Neurodegenerative Diseases

Cited by 105